The pharmaceutical Outsourcing Series consist of the following Contract Research and Contract Manufacturing titles...

Contract Research

Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
The 'Investigating Clinical Trial Costs' report analyses the background to these markets including a review of the relevant legislation and regulations governing the control of clinical trials in the key emerging markets as well as analysing the implications and factors which need to be taken into consideration when conducting clinical trials in these markets.
Table of contents |More information

Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
'Clinical Trial Recruitment Strategies' is a new report published by Business Insights that establish a contextual framework for patient recruitment planning and program management based on the latest trends in trial design and patient recruitment performance.
Table of contents |More information

The Future of R&D Outsourcing: Investigating development hurdles, key challenges & strategies to optimize CRO relationships
'The Future of R&D Outsourcing' is a new report published by Business Insights that provides in depth analysis of the types of different R–D outsourcing relationships, their advantages and disadvantages.
Table of contents |More information

The CRO Market Outlook To 2014: Emerging markets, leading players and future trends
'The CRO Market Outlook To 2014' is a new report published by Business Insights that provides insight into conditions into seven emerging regions including China, India and Latin America. It highlights the evolving business and relationship models between CROs and sponsor companies and enables optimal outsourcing strategy.
Table of contents |More information

Emerging Clinical Trial Locations: Market dynamics and the changing healthcare and regulatory environment
'Emerging Clinical Trial Locations' is a new report published by Business Insights that provides a comprehensive examination of the clinical trial landscape in emerging countries, with specific focus on China, India, Central and Eastern Europe and Latin America.
Table of contents |More information

Emerging Clinical Trial Locations – India: Market dynamics and the changing healthcare and regulatory environment
'Emerging Clinical Trial Locations – India: Market dynamics and the changing healthcare and regulatory environment' is a new report published by Business Insights that identifies market dynamics and key regulatory changes, and analyzes the implications and factors which need to be taken into consideration when conducting clinical trials in India.
Table of contents |More information

Emerging Clinical Trial Locations –Latin America: Market dynamics and the changing healthcare and regulatory environment
'Emerging Clinical Trial Locations – Latin America: Market dynamics and the changing healthcare and regulatory environment' is a new report published by Business Insights that identifies market dynamics and key regulatory changes, and analyzes the implications and factors which need to be taken into consideration when conducting clinical trials in Latin America.
Table of contents |More information

Emerging Clinical Trial Locations – China: Market dynamics and the changing healthcare and regulatory environment
'Emerging Clinical Trial Locations – China: Market dynamics and the changing healthcare and regulatory environment' is a new report published by Business Insights that identifies market dynamics and key regulatory changes, and analyzes the implications and factors which need to be taken into consideration when conducting clinical trials in China.
Table of contents |More information

Emerging Clinical Trial Locations – Eastern Europe: Market dynamics and the changing healthcare and regulatory environment
'Emerging Clinical Trial Locations – Eastern Europe: Market dynamics and the changing healthcare and regulatory environment' is a new report published by Business Insights that identifies market dynamics and key regulatory changes, and analyzes the implications and factors which need to be taken into consideration when conducting clinical trials in Eastern Europe.
Table of contents |More information

The Top 10 Contract Research Organizations: Positioning, performance and SWOT analyses
The Top 10 Contract Research Organizations’ is a new report published by Business Insights that examines the competitive landscape of the global CRO industry. The latest key issues and evolving business models in the CRO market are identified and the leading companies in this sector are profiled in detail.
Table of contents | Brochure | More information

Key Trends in Offshoring Pharmaceutical R&D: Company strategies, emerging markets and impact on ROI
‘Key Trends in Offshoring Pharmaceutical R&D’ is a new report published by Business Insights that evaluates the offshore R&D strategies that can reduce development times and improve productivity, with analysis of a variety of strategic partnerships, academic collaborations, and outsourcing opportunities.
Table of contents | Brochure | More information

Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
The industry for Pharmaceutical outsourcing in China has experienced high growth in recent years. Today, in addition to an increasing number of traditional Chinese pharmaceutical companies becoming involved in the full scope of contract manufacturing services, more and more new, professional outsourcing service providers have emerged.
Table of contents | Brochure | More information

Optimizing Partnerships with Contract Organizations
This report uses case studies of partnering strategies to highlight the most effective methods of reducing risk, in addition to evaluating the emerging trends and offshore outsourcing opportunities of markets such as Eastern Europe, China, India and Latin America.
Table of contents | Brochure | More information

The CRO Market Outlook
This report profiles the major international CRO players providing market share data and detailed analysis on current and future R&D spend.
Table of contents | Brochure | More information

Patient Recruitment and Retention in Clinical Trials
On a global basis, the drug development process is becoming increasingly complex, time consuming and expensive.
Table of contents | Brochure | More information

Winning R&D Productivity Strategies
Use this report to identify key areas of growth, effective strategies and innovative technologies to improve lead generation, attrition rates and return on investment from your portfolio.
Table of contents | Brochure | More information

Pharmaceutical Outsourcing Strategies
Over the last decade outsourcing has become an important strategic issue for pharmaceutical companies; rising pressure to reduce costs and time-to-market has led to outsourcing not only of traditional non-core functions such as manufacturing and clinical trials, but also increasingly of technically demanding areas such as drug discovery and biotech R&D.
Table of contents | Brochure | More information

Drug Development Opportunities in China
This report provides a comprehensive review of China’s drug development industry, both in terms of expanding domestic markets and the country’s role as a third-party provider of outsourced global drug developments.
Table of contents | Brochure | More information

Lead Optimization Strategies
More and more companies are resorting to streamlining their internal programs, both pre-clinical and clinical, to improve productivity and the cost-effectiveness of bringing drugs to the market.
Table of contents | Brochure | More information

Drug Safety in the Post-Vioxx Era
Develop a tighter drug safety strategy by analyzing nine case studies describing safety issues encountered by pharmaceutical companies and examine the predictions for the future of drug safety regulation in the US and EU.
Table of contents | Brochure | More information

The Future of Biosimilars
This report examines the current market and regulatory environment for biosimilars in Europe, India, China and the US, whilst identifying the trends that will shape future market development.
Table of contents | Brochure | More information

Contract Manufacturing

The CMO Market Outlook: Emerging markets, key players and future trends
'The CMO Market Outlook' analyzes the market dynamics, drivers and resistors and assesses the structure of the market. China and India are discussed as destinations for outsourced manufacturing including analyses of regulatory changes and patent protection. Industry strategies are detailed and critically examined. Key players in the global, Chinese and Indian markets are also assessed. The industry trends are examined and used to map out the future of the industry including the impact on the landscape of players.
Table of contents |More information

Key Players in Pharmaceutical Contract Manufacturing: Market developments, outsourcing hotspots and growth strategies
Key Players in Pharmaceutical Contract Manufacturing’ is a new report published by Business Insights that examines the competitive landscape of the global PCM industry. The latest key issues and developments in the contract manufacturing market are identified and leading companies in this sector are profiled in detail.
Table of contents | Brochure | More information

Contract Manufacturing Strategies: Market developments, technology transfer and key success factors
Contract Manufacturing Strategies’ is a new report published by Business Insights that explores the future of the contract manufacturing market with a detailed analysis of emerging drivers and restraints, business models and production strategies. The potential benefits and risks of contract manufacturing are assessed and the key strategies for effective CMO selection and successful relationship management are identified.
Table of contents | Brochure | More information

Biomanufacturing Strategies
Use this report to identify the key criteria involved in CMO selection, compare the expansion strategies and capacity shares of leading players and analyse the growth drivers shaping the future of biomanufacturing.
Table of contents | Brochure | More information

Pharmaceutical Growth Opportunities in Brazil, Russia, India and China
Benchmark your growth strategies against the top pharmaceutical companies operating in the BRIC markets, align your portfolio with future market opportunity and identify lucrative partnering opportunities to ensure you maximize the potential from these promising markets with this report.
Table of contents | Brochure | More information

The Biotechnology Market Outlook
This report will help you to evaluate the market opportunity that exists and outlines the key drivers and resistors to growth, providing best-practice growth strategies for early and late stage drug developers and integrated biotech companies.
Table of contents | Brochure | More information

The Biogenerics Market Outlook
This report identifies strategies for biogenerics success and evaluates the obstacles that need to be overcome in order to capture a share of this highly profitable, untapped market.
Table of contents | Brochure | More information

The Future of Monoclonal Antibody Therapeutics
This report profiles the major international CRO players providing market share data and detailed analysis on current and future R&D spend.
Table of contents | Brochure | More information